The post Hyperliquid: Why HYPE’s pullback from $38 could be healthy appeared on BitcoinEthereumNews.com. Journalist Posted: February 24, 2026 In a recent reportThe post Hyperliquid: Why HYPE’s pullback from $38 could be healthy appeared on BitcoinEthereumNews.com. Journalist Posted: February 24, 2026 In a recent report

Hyperliquid: Why HYPE’s pullback from $38 could be healthy

In a recent report, the large cluster of long liquidations below $30 for Hyperliquid [HYPE] led AMBCrypto to conclude that there was potential for a drop below $28 to hunt down the long positions.

This has since come true, aided by the Bitcoin [BTC] drop to $64.3k on Sunday. Hyperliquid was attracting capital, with high capital inflows to the ecosystem. This boded well for the token and the DEX in the long-term.

Based on the evidence at hand, HYPE bulls were setting up for an explosive rally. The macro conditions and BTC volatility were challenges that could delay the upward move, but the fundamentals were strong.

The 1-week chart has a bullish structure. The Fibonacci retracement levels showed that the fall to $20.48 in January was part of a retracement, with the golden pocket extending from $28.44 to $20.02.

Why you should think of buying this HYPE dip

The 1-day chart showed a bullish swing structure in place for HYPE. This occurred after the lower high at $28.4, set in the first week of January, was breached. That rally reached $38.42 in the first week of February.

It also outperformed major crypto assets by a sizeable margin. However, traders who bet on a bullish continuation faced losses and liquidations as the DEX token retraced its rally, falling below $30 on the 10th of February.

Yet, this was part of a healthy retracement. HYPE swing traders and investors can wait for the $24.3 level to be defended before looking to go long. This level was the 78.6% Fibonacci retracement level for the bullish swing move.

It also has confluence with an imbalance on the daily chart (white box) that could get filled.

A drop below $23.4 would be an early sign that the bulls lacked the strength to drive a recovery. In this scenario, traders and long-term buyers need to prepare for the bullish setup to get invalidated.

A move below $20 would confirm bearish strength, and buyers will need to wait for an internal structure shift before looking to go long again.


Final Summary

  • The Hyperliquid volatility in February was a bullish structure shift and a subsequent retracement.
  • Given that the weekly structure was also bullish and the $20 was a long-term support, HYPE appears nearly ready for its next rally.

Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion.

Next: ZRO slides 12% as token unlock pressure mounts: Spot buyers step in

Source: https://ambcrypto.com/hyperliquid-why-hypes-retracement-from-38-could-be-healthy/

Market Opportunity
Hyperliquid Logo
Hyperliquid Price(HYPE)
$28.34
$28.34$28.34
+5.78%
USD
Hyperliquid (HYPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion
Share
AI Journal2026/02/25 21:36
ZachXBT admits possible leak as insider trading speculation peaks on prediction markets

ZachXBT admits possible leak as insider trading speculation peaks on prediction markets

The post ZachXBT admits possible leak as insider trading speculation peaks on prediction markets appeared on BitcoinEthereumNews.com. ZachXBT admits he may have
Share
BitcoinEthereumNews2026/02/25 21:21